Vascular Reactivity Is Impaired and Associated With Walking Ability in Patients With Intermittent Claudication

Carregando...
Imagem de Miniatura
Citações na Scopus
10
Tipo de produção
article
Data de publicação
2015
Editora
SAGE PUBLICATIONS INC
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
SILVA, Rita de Cassia Gengo e
YUGAR-TOLEDO, Juan Carlos
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
ANGIOLOGY, v.66, n.7, p.680-686, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
We verified whether vascular reactivity is impaired and whether there is any association between vascular reactivity, walking ability, and peripheral artery disease (PAD) severity in patients with intermittent claudication (IC). We studied 63 patients and 17 age- and sex-matched volunteers without PAD. Vascular reactivity was evaluated in the brachial artery during reactive hyperemia (flow-mediated dilation [FMD]) and after a sublingual single dose of nitroglycerin (nitroglycerin-induced vasodilation [NID]). Walking ability was verified by a 6-minute walk test. Vascular reactivity and walking ability were significantly worse in patients with IC compared with control participants. The ankle-brachial index correlated with FMD, NID, as well as total and pain-free distances. The NID and walking ability progressively decreased as PAD severity increased. Walking ability correlated with NID but not with FMD. In patients with IC, vascular reactivity is impaired and is related to the severity of PAD and to walking ability.
Palavras-chave
peripheral arterial disease, intermittent claudication, vasodilation, muscle, smooth, vascular, endothelium, vascular, walking
Referências
  1. Akamatsu D, 2007, EUR J VASC ENDOVASC, V34, P639, DOI 10.1016/j.ejvs.2007.07.001
  2. Alam TA, 2005, EUR J VASC ENDOVASC, V29, P269, DOI 10.1016/j.ejvs.2004.12.019
  3. Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111
  4. Botti C, 2012, J BIOL REG HOMEOS AG, V26, P67
  5. Brevetti G, 2008, ATHEROSCLEROSIS, V197, P1, DOI 10.1016/j.atherosclerosis.2007.11.002
  6. Brevetti G, 2003, J VASC SURG, V38, P374, DOI 10.1016/S0741-5214(03)00124-1
  7. Brach JS, 2008, J AM GERIATR SOC, V56, P1037, DOI 10.1111/j.1532-5415.2008.01719.x
  8. Frans FA, 2013, J VASC SURG, V57, P720, DOI 10.1016/j.jvs.2012.09.044
  9. Gardner AW, 2004, J VASC SURG, V40, P73, DOI 10.1016/j.jvs.2004.02.010
  10. GIRIBELA CRG, 2011, REV BRASILEIRA HIPER, V18, P27
  11. Grenon SM, 2014, J VASC SURG, V59, P1025, DOI 10.1016/j.jvs.2013.10.084
  12. Gutierrez MA, 2002, COMPUT CARDIOL, V29, P359
  13. HIATT WR, 1995, CIRCULATION, V91, P1472
  14. Hirsch AT, 2014, ACC AHA GUIDELINES M
  15. Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6
  16. Komai H, 2008, ANGIOLOGY, V59, P52, DOI 10.1177/0003319707303442
  17. Lind L, 2011, CLIN PHYSIOL FUNCT I, V31, P182, DOI 10.1111/j.1475-097X.2010.00996.x
  18. McDermott MM, 2009, J AM COLL CARDIOL, V53, P1056, DOI 10.1016/j.jacc.2008.09.063
  19. McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453
  20. Meru AV, 2006, ATHEROSCLEROSIS, V187, P221, DOI 10.1016/j.atherosclerosis.2005.11.027
  21. MIRALLES JD, 2009, INTERACT CARDIOV TH, V9, P107
  22. Munzel T, 2008, ANN MED, V40, P180, DOI 10.1080/07853890701854702
  23. Paraskevas KI, 2013, ANGIOLOGY, V64, P569, DOI 10.1177/0003319712466730
  24. Silvestro A, 2003, VASC MED, V8, P225, DOI 10.1191/1358863x03vm503oa
  25. Thomas DR, 2013, CLIN GERIATR MED, V29, P425, DOI 10.1016/j.cger.2013.01.010
  26. Wolosker N, 2003, ARCH INTERN MED, V163, P2296, DOI 10.1001/archinte.163.19.2296
  27. Yataco AR, 1999, AM J CARDIOL, V83, P754, DOI 10.1016/S0002-9149(98)00984-9